NXERA
Pharmaceutical preparations for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing GPCR-mediated or GPCR-implicated diseases and disorders; Medicines for modulating G-protein-coupled receptors, transmembrane proteins and parts thereof for treating and preventing GPCR-mediated or GPCR-implicated diseases and disorders; biological products for medical purposes, namely, G-protein coupled receptors for modulating G-protein-coupled receptor...
Pending · February 13, 2024 · 98404554 ·